Icrucumab

Product Specifications

CAS Number

1024603-92-6

Target

VEGFR

Related Pathways

Tyrosine Kinase/Adaptors|||Angiogenesis

Purity

>95%

Bioactivity

Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

A106682 100 µL

Anti-[KO Validated] CDKN1A/p21 (Rabbit, Monoclonal)

Ask

View Details

MBS7112907-01 0.05 mg

DBT Antibody, Biotin Conjugated

Ask

View Details

MBS7112907-02 0.1 mg

DBT Antibody, Biotin Conjugated

Ask

View Details

MBS7112907-03 5x 0.1 mg

DBT Antibody, Biotin Conjugated

Ask

View Details

bsm-62342R-BF594-01 20 µL

Nm23-H2/NME2 Recombinant Antibody, AbBy Fluor™ 594 Conjugated

Ask

View Details

bsm-62342R-BF594-02 100 µL

Nm23-H2/NME2 Recombinant Antibody, AbBy Fluor™ 594 Conjugated

Ask

View Details